LNSR - NASDAQ

LENSAR, Inc.

LNSR·NASDAQ

$5.74

-2.0%

HealthcareMedical - Devices

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$69.48M

EPS-2.8700

P/E Ratio-2.00

Earnings Date08/06/2026

lnsr

Cash at Beginning of Period

Last Annual Value

16.26M

3-Year CAGR

-20%

5-Year CAGR

28%

10-Year CAGR

22%

Adjust for Inflation

LENSAR, Inc. Competitors Analysis of Cash at Beginning of Period

LNSR · NASDAQ

Company	Cash at Beginning of Period	CAGR 3Y	CAGR 5Y	CAGR 10Y
LENSAR, Inc. NASDAQ:LNSR	16.26M	3.5%	-16.7%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	51.47M	46.6%	-17.0%	-2.7%
TriSalus Life Sciences, Inc. NASDAQ:TLSI	8.88M	-2.8%	14.6%	N/A
Sight Sciences, Inc. NASDAQ:SGHT	120.36M	-13.4%	14.4%	N/A
Apyx Medical Corporation NASDAQ:APYX	31.74M	46.0%	-5.4%	10.4%
Hyperfine, Inc. NASDAQ:HYPR	37.67M	-31.7%	-10.1%	N/A
Lucid Diagnostics Inc. NASDAQ:LUCD	22.36B	898.3%	1049.8%	N/A
AVITA Medical, Inc. NASDAQ:RCEL	14.05M	-8.2%	-28.2%	N/A
Spero Therapeutics, Inc. NASDAQ:SPRO	52.89M	-21.4%	-9.1%	25.0%
Rapid Micro Biosystems, Inc. NASDAQ:RPID	17.28M	-14.2%	-10.6%	N/A
Owlet, Inc. NYSE:OWLT	20.63M	22.5%	3.9%	N/A

LENSAR, Inc. Fair Value Envelope

LNSR · NASDAQ

Our analysis suggests that LNSR has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $5.74, this represents a potential HIDDEN relative to our calculated worth for LENSAR, Inc..

HIDDEN

Intrinsic Value

Current Price: $5.74

Related Guides

Blog Categories

Continue your LNSR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.